Human Investing’s Accendra Health ACH Stock Holding History

Human Investing’s Portfolio ACH Stock Details ACH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,832	Closed	-$69K	–	233
2021 Q1	$69K	Buy	+1,832	New	+$57.3K	0.02%	146

Other funds holding ACH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Human Investing's ACH Position: Q2 2021 in Review

Human Investing sold out of Accendra Health (ACH) in Q2 2021, closing a stake of 1,832 shares — an estimated $69K sold.

Human Investing first reported a position in ACH in Q1 2021 and held it in 1 quarter. The position peaked at $69K in Q1 2021. 260 funds tracked by Wall St. Rank hold ACH as of Q2 2021.

Human Investing reported no remaining Accendra Health position as of Q2 2021 after selling out during the quarter.
Human Investing sold 1,832 Accendra Health shares in Q2 2021, an estimated $69K.
Human Investing first reported a position in Accendra Health in Q1 2021 and held it in 1 quarter.
Human Investing's Accendra Health position peaked at $69K in Q1 2021.
260 funds tracked by Wall St. Rank held Accendra Health as of Q2 2021.

Based on Human Investing's 13F filing for Q2 2021, filed 2 Aug 2021.